Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

VMD
Viemed Healthcare Inc
NASDAQ
6.86
Open 6.92 Prev Close 6.93
High 6.95 Low 6.71
Volume 194,844 Volume (Avg) 246
52 Week High 9.81 52 Week Low 5.93
Market Cap 266.1M PE Ratio 20.24

Shares Stats

Shares Outstanding39,610,000
Shares Float33,690,000
Shares Short460,000
Insider Holdings1325%
Institution Holdings67.21%

About Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

General

NameViemed Healthcare Inc
TickerVMD
ExchangeNASDAQ
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees1,258

Highlights

Analyst Target13.00
Market Cap266,100,000
PE Ratio20.24
EBITDA42,878,000

Financials

Curr Year EPS Estimate0.43
Profit Margin5.80%
Operating Margin6.89
Return on Assets0.06
Return on Equity0.11
Revenue240.9M
Earnings Per Share0.34
Revenue Per Share6.14
Gross Profit140,519,008
Quarterly Revenue Growth0.15

Valuation

Trailing PE20.38
Forward PE16.89
Price/Sales (Trailing 12 Mt.)1.12
Price/Book (Most Recent Quarter)1.88

Earnings

Most Popular

Trump administration cuts nearly $8B in clean energy projects in blue states

WASHINGTON (AP) — The Trump administration is cancelling $7.6 billion in grants that supported hundreds of clean energy projects in 16 states, all of which voted for Democrat Kamala Harris in last year's presidential election.

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Two Delta jets damaged in 'low-speed collision' on LaGuardia taxiway, injuring 1

Two Delta Air Lines regional jets collided on the taxiway at LaGuardia Airport in New York, injuring a flight attendant, damaging a cockpit and tearing off part of a wing in what the airline described as a “low-speed collision.”

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Consumer Tech News (Sep. 15 – Sep. 19): Fed Rate Cut Lifts Wall Street To Records As Meta Unveils Smart Glasses, Nvidia-Intel Forge Chip Pact

Wall Street rallied to record highs after the Fed's rate cut, while Meta launched new smart glasses, Nvidia teamed with Intel on chips, and big names like General Mills, FedEx, and Darden reported earnings.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

Jensen Huang Is A 'Good Friend,' Says Intel CEO Lip-Bu Tan Amid News Of Partnership With Nvidia: Next Era Of Computing Coming?

Intel shares surged more than 20% after CEO Lip-Bu Tan announced a landmark partnership with Nvidia's Jensen Huang to co-develop AI chips, a deal that includes a $5 billion Nvidia investment and positions both companies at the center of the next era of computing.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT

Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Bitcoin, Ethereum, Dogecoin Consolidate As XRP Tries To Push Higher

Cryptocurrency markets are trading sideways on Tuesday as investors position ahead of the Federal Reserve's interest rate decision.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Australia warns social media platforms against age verification for all ahead of a ban on children

MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Anthony Scaramucci Says A Tesla–xAI Merger 'Feels Inevitable' As Shareholders Push For Investment In Grok Parent

Anthony Scaramucci said a Tesla–xAI merger "feels inevitable," amplifying shareholder pressure and investor debate as Musk backs closer ties between the EV maker and his $100 billion AI startup.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet

Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.

In battles over free speech, comedians are often center stage

NEW YORK (AP) — Bassem Youssef, the Egyptian satirist whose after the military seized the once pro-democracy government, watched the suspension of Jimmy Kimmel with an immediate sense of familiarity.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Opendoor Stock Rallies On Expansion And Short Squeeze Hopes

Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service